It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The intestinal anaerobic bacterium Akkermansia muciniphila is specialized in the degradation of mucins, which are heavily O-glycosylated proteins that constitute the major components of the mucus lining the intestine. Despite that adhesion to mucins is considered critical for the persistence of A. muciniphila in the human intestinal tract, our knowledge of how this intestinal symbiont recognizes and binds to mucins is still limited. Here, we first show that the mucin-binding properties of A. muciniphila are independent of environmental oxygen concentrations and not abolished by pasteurization. We then dissected the mucin-binding properties of pasteurized A. muciniphila by use of a recently developed cell-based mucin array that enables display of the tandem repeats of human mucins with distinct O-glycan patterns and structures. We found that A. muciniphila recognizes the unsialylated LacNAc (Galβ1-4GlcNAcβ1-R) disaccharide selectively on core2 and core3 O-glycans. This disaccharide epitope is abundantly found on human colonic mucins capped by sialic acids, and we demonstrated that endogenous A. muciniphila neuraminidase activity can uncover the epitope and promote binding. In summary, our study provides insights into the mucin-binding properties important for colonization of a key mucin-foraging bacterium.
Intestinal mucus consists of densely O-glycosylated mucins, serving as a nutrient source for bacteria. Elzinga et al. show that mucin-degrading Akkermansia muciniphila selectively binds to O-glycan structures found on human colonic mucins.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Wageningen University & Research, Laboratory of Microbiology, Wageningen, The Netherlands (GRID:grid.4818.5) (ISNI:0000 0001 0791 5666); Faculty of Health Sciences, University of Copenhagen, Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
2 Faculty of Health Sciences, University of Copenhagen, Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); GlycoDisplay ApS, Copenhagen, Denmark (GRID:grid.510946.f)
3 Faculty of Health Sciences, University of Copenhagen, Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978)
4 Faculty of Health Sciences, University of Copenhagen, Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
5 Wageningen University & Research, Laboratory of Microbiology, Wageningen, The Netherlands (GRID:grid.4818.5) (ISNI:0000 0001 0791 5666); Faculty of Medicine, University of Helsinki, Human Microbiome Research Program, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
6 Wageningen University & Research, Laboratory of Microbiology, Wageningen, The Netherlands (GRID:grid.4818.5) (ISNI:0000 0001 0791 5666); Nestlé Research, Nestlé Institute of Health Sciences, Lausanne, Switzerland (GRID:grid.419905.0) (ISNI:0000 0001 0066 4948)